• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends



EVERSANA™, a pioneer of next-generation commercial services to the global life sciences industry, today unveiled EVERSANA INTOUCH, marking the transformation of its full-service, global healthcare agency network serving the life sciences industry.

EVERSANA INTOUCH was formed from the integration of Intouch Group®, acquired in December 2021, and EVERSANA ENGAGE. Together the agency network now includes more than 1,800 marketers and eight locations across North America, as well as EVERSANA’s more than 40 locations worldwide.

“Stakeholder engagement across the product and patient journeys is more complex than ever. Traditional agencies do a formidable job promoting brands to physicians, payers, and patients, but EVERSANA INTOUCH isn’t just another agency,” said Jim Lang, CEO, EVERSANA. “Building from Intouch’s transformation of pharmaceutical promotion and digital engagement, we’ve connected that expertise to our commercial engine – propelled by millions of dollars invested in data and analytics –to track, optimize and accelerate brand success from launch to loss of exclusivity and beyond.”

Related Videos
Related Content